Contents
|
|
|
TREATMENT
OPTIONS
■
CARBOPLATIN
■ HYPERTHERMIA
■ IMMUNOTHERAPY
■
MONOCLONAL
ANTIBODIES
■
NIMUSTINE
■ PROTEIN
KINASE INHIBITORS
■
RE-IRRADIATION
■
RE-RESECTION
■
STEREOTACTIC
RADIOTHERAPY
■
TEMOZOLOMIDE
|
|
|
Overview
|
|
.
|
Khan
MN, Sharma AM, Pitz M, Loewen SK, Quon H, Poulin A, Essig M.
High-grade
glioma management and response assessment-recent advances and
current challenges.
Curr
Oncol. 2016 Aug;23(4):e383-91. doi: 10.3747/co.23.3082. Epub 2016
Aug 12.
Source
|
Full
text |
Similar
articles
|
|
|
.
|
Ishikawa E, Muragaki Y, Yamamoto T, Ohno T, Matsumura A.
Vaccine
Therapy of High-Grade Gliomas
Prog Neurol Surg. Basel,
Karger, 2018, vol 32, pp 101-111 (DOI:10.1159/000469684).
Published online: July 10, 2018.
Source
| Full
text
|
|
|
.
|
Miyatake S-I, Kawabata S, Hiramatsu R, Kuroiwa T, Suzuki M, Ono K.
Boron Neutron Capture Therapy of Malignant Gliomas
Prog Neurol Surg. Basel, Karger, 2018, vol 32, pp 48-56
(DOI:10.1159/000469679). Published online: July 10, 2018.
Source
| Full
text
|
|
|
.
|
Paldor I, Chaichana KL, Brem H, Tyler BM.
Targeted Local
Therapy for Management of Intracranial High-Grade Gliomas
Prog Neurol Surg. Basel, Karger, 2018, vol 32, pp 159-171
(DOI:10.1159/000469688). Published online: July 10, 2018.
Source
| Full
text
|
|
|
.
|
Prabhu SS.
Convection-Enhanced Delivery for Management of
Malignant Gliomas
Prog Neurol Surg. Basel, Karger, 2018,
vol 32, pp 152-158 (DOI:10.1159/000469687). Published online: July
10, 2018.
Source
| Full
text
|
|
|
.
|
Ruff MW, Uhm J.
Anaplastic Glioma: Treatment Approaches
in the Era of Molecular Diagnostics.
Curr Treat Options
Oncol. 2018 Oct 25;19(12):61. doi: 10.1007/s11864-018-0579-0.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Serventi J, Behr J.
Surgery and Evidence-based Treatments
in Patients with Newly Diagnosed High-grade Glioma.
Semin
Oncol Nurs. 2018 Dec;34(5):443-453. doi:
10.1016/j.soncn.2018.10.009. Epub 2018 Nov 5.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Wong ET, Lok E, Swanson K.D.
Alternating Electric Fields
Therapy for Malignant Gliomas: From Bench Observation to Clinical
Reality
Prog Neurol Surg. Basel, Karger, 2018, vol 32,
pp 180-195 (DOI:10.1159/000469690). Published online: July 10,
2018.
Source
| Full
text
|
|
|
.
|
Yoon JW, Jiang W, Rutka JT, Huang Y, Kim BYS.
Perspectives
of Nanotechnology in the Management of Gliomas
Prog
Neurol Surg. Basel, Karger, 2018, vol 32, pp 196-210
(DOI:10.1159/000469691). Published online: July 10, 2018.
Source
| Full
text
|
|
|
PEDIATRIC
HIGH-GRADE GLIOMA
|
|
.
|
Bailey CP, Figueroa M, Mohiuddin S, Zaky W, Chandra J.
Cutting
Edge Therapeutic Insights Derived from Molecular Biology of
Pediatric High-Grade Glioma and Diffuse Intrinsic Pontine Glioma
(DIPG).
Bioengineering (Basel). 2018 Oct 18;5(4). pii:
E88. doi: 10.3390/bioengineering5040088.
Source
| Full
text |
Similar
articles
|
|
|
CANNABINOIDS
|
|
.
|
Kenyon J, Liu W, Dalgleish A.
Report of Objective
Clinical Responses of Cancer Patients to Pharmaceutical-grade
Synthetic Cannabidiol.
Anticancer Res. 2018
Oct;38(10):5831-5835. doi: 10.21873/anticanres.12924.
Source
| Full
text |
Similar
articles
|
|
|
CHEMOTHERAPY
|
|
.
|
Bouffet
E, Ramaswamy V.
Old
chemotherapy makes a comeback: dual alkylator therapy for
pediatric high-grade glioma.
Neuro
Oncol. 2016 Oct;18(10):1333-4. doi: 10.1093/neuonc/now200. Epub
2016 Sep 23.
Source
|
Full
text |
Similar
articles
|
|
|
.
|
Wen
W, Guang S, Binbin M, Xiangcheng H, Xin D, Bo Z.
Chemotherapy
for Adults with Malignant Glioma: A Systematic Review and Network
Meta-analysis.
Turk
Neurosurg. 2015 Aug 25. doi: 10.5137/1019-5149.JTN.15462-15.0.
[Epub ahead of print]
Source
|
Full
text |
Similar
articles
|
|
|
PHOTODYNAMIC
THERAPY
|
|
.
|
Mahmoudi K, Garvey KL, Bouras A, Cramer G, Stepp H, Jesu Raj JG,
Bozec D, Busch TM, Hadjipanayis CG.
5-aminolevulinic acid
photodynamic therapy for the treatment of high-grade gliomas.
J
Neurooncol. 2019 Feb;141(3):595-607. doi:
10.1007/s11060-019-03103-4. Epub 2019 Jan 18.
Source
| Full
text | Similar
articles
|
|
|
RADIOTHERAPY
|
|
.
|
Ge X, Xue X, Liu H, Wang Y, Xiao Z, Tian L, Chang X, Lin Q, Yu J.
Treatment of high-grade gliomas using escalating doses of
hypofractionated simultaneous integrated boost-intensity-modulated
radiation therapy in combination with temozolomide: A modified
Phase I clinical trial.
J Cancer Res Ther.
2018;14(7):1482-1491. doi: 10.4103/jcrt.JCRT_51_18.
Date of Web Publication: 19-Dec-2018
Source
| Full
text | Similar
articles
|
|
|
.
|
Guram K, Smith M, Ginader T, Bodeker K, Pelland D, Pennington E,
Buatti JM.
Using smaller-than-standard radiation
treatment margins does not change survival outcomes in patients
with high-grade gliomas.
Pract Radiat Oncol. 2018 Jun 5.
pii: S1879-8500(18)30198-X. doi: 10.1016/j.prro.2018.06.001. [Epub
ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
SURGERY
|
|
.
|
Renfrow
JJ, Strowd RE, Laxton AW, Tatter SB, Geer CP, Lesser GJ.
Surgical
Considerations in the Optimal Management of Patients with
Malignant Brain Tumors.
Curr
Treat Options Oncol. 2017 Aug;18(8):46. doi:
10.1007/s11864-017-0487-8. Online 2017 Jul 5.
Source
|
Full
text |
Similar
articles
|
|
|
TARGETED
THERAPY
|
|
.
|
Chen
R, Cohen AL, Colman H.
Targeted
Therapeutics in Patients With High-Grade Gliomas: Past, Present,
and Future.
Curr
Treat Options Oncol. 2016 Aug;17(8):42. doi:
10.1007/s11864-016-0418-0. Epub 2016 Jun 22
Source
|
Full
text |
Similar
articles
|
|
|
Laboratory
investigations
|
|
|
|
CONVERSION
IN GLIAL CELLS
|
|
.
|
Oh J, Kim Y, Baek D, Ha Y.
Malignant gliomas can be
converted to non‑proliferating glial cells by treatment with
a combination of small molecules.
Oncol Rep. 2019
Jan;41(1):361-368. doi: 10.3892/or.2018.6824. Epub 2018 Oct 25.
Source
| Full
text | Similar
articles
|
|
|
DIFFERENTIATION
|
|
.
|
Wang
Y, Huang N, Li H, Liu S, Chen X, Yu S, Wu N, Bian XW, Shen HY, Li
C, Xiao L.
Promoting
oligodendroglial-oriented differentiation of glioma stem cell: A
repurposing of quetiapine for the treatment of malignant glioma.
Oncotarget.
2017 Mar 21. doi: 10.18632/oncotarget.16400. [Epub ahead of print]
Source
|
Full
text |
Similar
articles
|
|
|
Clinical
investigations
|
|
|
|
ANTIANGIOGENIC
THERAPY
|
|
.
|
Ameratunga M, Pavlakis N, Wheeler H, Grant R, Simes J, Khasraw M.
Anti-angiogenic therapy for high-grade glioma.
Cochrane Database Syst Rev. 2018 Nov 22;11:CD008218. doi:
10.1002/14651858.CD008218.pub4.
Source
|
Abstract
|
Similar
articles
|
|
|
.
|
Grill J, Massimino M, Bouffet E, Azizi AA, McCowage G, Cañete
A, Saran F, Le Deley MC, Varlet P, Morgan PS, Jaspan T, Jones C,
Giangaspero F, Smith H, Garcia J, Elze MC, Rousseau RF, Abrey L,
Hargrave D, Vassal G.
Phase II, Open-Label, Randomized,
Multicenter Trial (HERBY) of Bevacizumab in Pediatric Patients
With Newly Diagnosed High-Grade Glioma.
J Clin Oncol.
2018 Feb 7:JCO2017760611. doi: 10.1200/JCO.2017.76.0611. [Epub
ahead of print]
Source
|
Abstract
|
Similar
articles
|
>>>
|
|
|
Yonezawa
H, Hirano H, Uchida H, Habu M, Hanaya R, Oyoshi T, Sadamura Y,
Hanada T, Tokimura H, Moinuddin F, Arita K.
Efficacy
of bevacizumab therapy for unresectable malignant glioma: A
retrospective analysis.
Mol
Clin Oncol. 2017 Jan;6(1):105-110. doi: 10.3892/mco.2016.1086.
Epub 2016 Nov 18.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
CHEMOTHERAPY
|
|
.
|
Bae JW, Hong EK, Gwak HS.
Response of Leptomeningeal
Dissemination of Anaplastic Glioma to Temozolomide: Experience of
Two Cases.
Brain Tumor Res Treat. 2017 Oct;5(2):99-104.
doi: 10.14791/btrt.2017.5.2.99. Epub 2017 Oct 31.
Source
| Full
text |
Similar
articles
|
|
|
|
Xu
W, Li T, Gao L, Zheng J, Shao A, Zhang J.
Efficacy
and safety of long-term therapy for high-grade glioma with
temozolomide: A meta-analysis.
Oncotarget.
2017 Apr 24;8(31):51758-51765. doi: 10.18632/oncotarget.17401.
eCollection 2017 Aug 1.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
KINASE
INHIBITORS
|
|
.
|
Hottinger AF, Aissa AB, Espeli V, Squiban D, Dunkel N, Vargas MI,
Hundsberger T, Mach N, Schaller K, Weber DC, Bodmer A, Dietrich
PY.
Phase I study of sorafenib combined with radiation
therapy and temozolomide as first-line treatment of high-grade
glioma.
Br J Cancer. 2014 May 27;110(11):2655-61. doi:
10.1038/bjc.2014.209. Epub 2014 May 1. Erratum in: Br
J Cancer. 2018 Jan 09.
Source
| Full
text |
Similar
articles | Erratum
|
|
|
.
|
Hottinger AF, Ben Aissa A, Espeli V, Squiban D, Dunkel N, Vargas
MI, Hundsberger T, Mach N, Schaller K, Weber DC, Bodmer A,
Dietrich PY.
Phase
I study of sorafenib combined with radiation therapy and
temozolomide as first-line treatment of high-grade glioma.
Br J Cancer. 2018 Jan 9. doi: 10.1038/bjc.2017.469. [Epub
ahead of print]
Correction
to: Hottinger AF et al, Phase I study of sorafenib combined with
radiation therapy and temozolomide as first-line treatment of
high-grade glioma. Br J Cancer. 2014 May 27;110(11):2655-61. doi:
10.1038/bjc.2014.209. Epub 2014 May 1. Source
,
Full
text
Source
| Full
text |
Similar
articles
|
|
|
PEDIATRIC
PATIENTS
|
|
|
Jakacki
RI, Cohen KJ, Buxton A, Krailo MD, Burger PC, Rosenblum MK, Brat
DJ, Hamilton RL, Eckel SP, Zhou T, Lavey RS, Pollack IF.
Phase
2 study of concurrent radiotherapy and temozolomide followed by
temozolomide and lomustine in the treatment of children with
high-grade glioma: a report of the Children's Oncology Group
ACNS0423 study.
Neuro
Oncol. 2016 Mar 22. pii: now038. [Epub ahead of print]
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
|
Massimino
M, Biassoni V.
Use
of high-dose chemotherapy in front-line therapy of childhood
malignant glioma.
Expert
Rev Anticancer Ther. 2006 May;6(5):709-17.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
|
Massimino
M, Gandola L, Luksch R, Spreafico F, Riva D, Solero C, Giangaspero
F, Locatelli F, Podda M, Bozzi F, Pignoli E, Collini P, Cefalo G,
Zecca M, Casanova M, Ferrari A, Terenziani M, Meazza C, Polastri
D, Scaramuzza D, Ravagnani F, Fossati-Bellani F.
Sequential
chemotherapy, high-dose thiotepa, circulating progenitor cell
rescue, and radiotherapy for childhood high-grade glioma.
Neuro
Oncol. 2005 Jan;7(1):41-8.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
RADIOTHERAPY
|
|
|
Adeberg
S, Harrabi SB, Bougatf N, Bernhardt D, Rieber J, Koerber SA, Syed
M, Sprave T, Mohr A, Abdollahi A, Haberer T, Combs SE, Herfarth K,
Debus J, Rieken S.
Intensity-modulated
proton therapy, volumetric-modulated arc therapy, and 3D conformal
radiotherapy in anaplastic astrocytoma and glioblastoma : A
dosimetric comparison.
Strahlenther
Onkol. 2016 Nov;192(11):770-779. Epub 2016 Jun 22.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
|
Nathan
JK, Brezzell AL, Kim MM, Leung D, Wilkinson DA, Hervey-Jumper SL.
Early
initiation of chemoradiation following index craniotomy is
associated with decreased survival in high-grade glioma.
J
Neurooncol. 2017 Jul 25. doi: 10.1007/s11060-017-2577-7. [Epub
ahead of print]
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
TUMOR
TREATING FIELDS
|
|
.
|
Anthony P, McArdle S, McHugh M.
Tumor Treating Fields:
Adjuvant Treatment for High-grade Gliomas.
Semin Oncol
Nurs. 2018 Dec;34(5):454-464. doi: 10.1016/j.soncn.2018.10.007.
Epub 2018 Nov 7.
Source
| Full
text |
Similar
articles
|
|
|
Newly
diagnosed or recurrent tumors
|
|
.
|
Johanns TM, Ferguson CJ, Grierson PM, Dahiya S, Ansstas G.
Rapid
Clinical and Radiographic Response With Combined Dabrafenib and
Trametinib in Adults With BRAF-Mutated
High-Grade Glioma.
J Natl Compr Canc Netw. 2018
Jan;16(1):4-10. doi: 10.6004/jnccn.2017.7032.
Source
| Full
text |
Similar
articles
|
|
|
WITHAFERIN
A
|
|
|
Marlow
MM, Shah SS, Véliz EA, Ivan ME, Graham RM.
Treatment
of adult and pediatric high-grade gliomas with Withaferin A:
antitumor mechanisms and future perspectives.
J
Nat Med. 2016 Jul 2. [Epub ahead of print]
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
Recurrent
tumors
|
|
|
|
OVERVIEW
|
|
.
|
Laub CK, Stefanik J, Doherty L.
Approved Treatments for
Patients with Recurrent High-grade Gliomas.
Semin Oncol
Nurs. 2018 Dec;34(5):486-493. doi: 10.1016/j.soncn.2018.10.005.
Epub 2018 Nov 2.
Source
| Full
text |
Similar
articles
|
|
|
|
Schwartz
C, Thon N, Winkler PA.
Therapeutic
Options for Recurrent High-grade Gliomas - A Perspective
Statement.
World
Neurosurg. 2017 Apr 19. pii: S1878-8750(17)30571-5. doi:
10.1016/j.wneu.2017.04.076. [Epub ahead of print]
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
ANTI-ANGIOGIENIC
THERAPY
|
|
|
de
Lemos ML, Markarian A, Chan E, Schaff K, Walisser S.
Clinical
effectiveness of bevacizumab in patients with recurrent brain
tumours: A population-based evaluation.
J
Oncol Pharm Pract. 2016 Nov 30. pii: 1078155216681191. [Epub ahead
of print]
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
.
|
Jeck J, Kassubek R, Coburger J, Edenhofer S, Schönsteiner SS,
Ludolph AC, Schmitz B, Engelke J, Mayer-Steinacker R, Lewerenz J,
Bullinger L.
Bevacizumab in temozolomide refractory
high-grade gliomas: single-centre experience and review of the
literature.
Ther Adv Neurol Disord. 2018 Jan
21;11:1756285617753597. doi: 10.1177/1756285617753597. eCollection
2018.
Source
| Full
text |
Similar
articles
|
|
|
CXCR4
INHIBITOR
|
|
.
|
Lee EQ, Duda DG, Muzikansky A, Gerstner E, Kuhn JG, Reardon DA,
Nayak L, Norden AD, Doherty L, LaFrankie D, Stefanik J, Vardam T,
Smith KH, McCluskey C, Gaffey SC, Batchelor T, Jain RK, Wen PY.
Phase I and biomarker study of plerixafor and bevacizumab
in recurrent high-grade glioma.
Clin Cancer Res. 2018
Jun 25. pii: clincanres.1025.2018. doi:
10.1158/1078-0432.CCR-18-1025. [Epub ahead of print]
Source
|
Abstract
| Full
text |
Similar
articles
|
|
|
BRACHYTHERAPY
|
|
|
Suchorska
B, Hamisch C, Treuer H, Mahnkopf K, Lehrke RE, Kocher M, Ruge MI,
Voges J.
Stereotactic
brachytherapy using iodine 125 seeds for the treatment of primary
and recurrent anaplastic glioma WHO° III.
J
Neurooncol. 2016 Oct;130(1):123-131. Epub 2016 Jul 15.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
CHEMOTHERAPY
|
|
|
Aoki
T, Arakawa Y, Ueba T, Oda M, Nishida N, Akiyama Y, Tsukahara T,
Iwasaki K, Mikuni N, Miyamoto S.
Phase
I/II Study of Temozolomide Plus Nimustine Chemotherapy for
Recurrent Malignant Gliomas: Kyoto Neuro-oncology Group.
Neurol
Med Chir (Tokyo). 2016 Oct 11. [Epub ahead of print]
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
|
Chamberlain
MC, Colman H, Kim BT, Raizer J.
Salvage
therapy with bendamustine for temozolomide refractory recurrent
anaplastic gliomas: a prospective phase II trial.
J
Neurooncol. 2017 Feb 16. doi: 10.1007/s11060-016-2241-7. [Epub
ahead of print]
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
|
Parasramka
S, Talari G, Rosenfeld M, Guo J, Villano JL.
Procarbazine,
lomustine and vincristine for recurrent high-grade glioma.
Cochrane
Database Syst Rev. 2017 Jul 26;7:CD011773. doi:
10.1002/14651858.CD011773.pub2.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
|
Wong
ET, Timmons J, Callahan A, O'Loughlin L, Giarusso B, Alsop DC.
Phase
I study of low-dose metronomic temozolomide for recurrent
malignant gliomas.
BMC
Cancer. 2016 Nov 22;16(1):914.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
CARMUSTINE
WAFER
|
|
|
Roux A, Caire F, Guyotat J, Menei P, Metellus P, Pallud J;
Neuro-Oncology Club of the French Neurosurgical Society.
Carmustine wafer implantation for high-grade gliomas:
Evidence-based safety efficacy and practical recommendations from
the Neuro-oncology Club of the French Society of Neurosurgery.
Neurochirurgie. 2017 Dec;63(6):433-443. doi:
10.1016/j.neuchi.2017.07.003. Epub 2017 Nov 6.
Source
|
Abstract
| Full
text |
Similar
articles
|
|
|
FOTEMUSTINE
|
|
.
|
Addeo R, Caraglia M, De Santi MS, Montella L, Abbruzzese A,
Parlato C, Vincenzi B, Carraturo M, Faiola V, Genovese M, Cennamo
G, Del Prete S.
A new schedule of fotemustine in
temozolomide-pretreated patients with relapsing glioblastoma.
J
Neurooncol. 2011 May;102(3):417-24. doi:
10.1007/s11060-010-0329-z. Epub 2010 Aug 10. Dosage error in
published abstract. Correction in: J
Neurooncol. 2011 May;102(3):425. Epub 2010 Sep
21.
Source
| Full
text | Similar
articles | Erratum
|
|
|
.
|
Prelaj A, Rebuzzi SE, Grassi M, Salvati M, D'Elia A, Buttarelli F,
Ferrara C, Tomao S, Bianco V.
Non-conventional
fotemustine schedule as second-line treatment in recurrent
malignant gliomas: Survival across disease and treatment subgroup
analysis and review of the literature.
Mol Clin Oncol.
2019 Jan;10(1):58-66. doi: 10.3892/mco.2018.1746. Epub 2018 Oct
16.
Source
| Full
text | Similar
articles
Referring
to: Addeo R et al, A new schedule of fotemustine in
temozolomide-pretreated patients with relapsing glioblastoma.
J
Neurooncol. 2011 May;102(3):417-24. doi:
10.1007/s11060-010-0329-z. Epub 2010 Aug 10. Dosage error in
published abstract. Correction in: J
Neurooncol. 2011 May;102(3):425.
Epub 2010 Sep 21. Source
,
Full
text ,
Erratum
|
|
|
GENE
THERAPY
|
|
.
|
Philbrick BD, Adamson DC.
Early clinical trials of Toca
511 and Toca FC show a promising novel treatment for recurrent
malignant glioma.
Expert Opin Investig Drugs. 2019
Mar;28(3):207-216. doi: 10.1080/13543784.2019.1572112.
Source
| Full
text | Similar
articles
|
|
|
|
Portnow
J, Synold TW, Badie B, Tirughana R, Lacey SF, D'Apuzzo M, Metz MZ,
Najbauer J, Bedell V, Vo T, Gutova M, Frankel P, Chen MY, Aboody
KS.
Neural
stem cell-based anti-cancer gene therapy: a first-in-human study
in recurrent high grade glioma patients.
Clin
Cancer Res. 2016 Dec 15. pii: clincanres.1518.2016. [Epub ahead of
print]
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
HISTONE
DEACETYLASE INHIBITORS
|
|
|
|
PANOBINOSTAT
|
|
|
Shi
W, Palmer JD, Werner-Wasik M, Andrews DW, Evans JJ, Glass J, Kim
L, Bar-Ad V, Judy K, Farrell C, Simone N, Liu H, Dicker AP,
Lawrence YR.
Phase
I trial of panobinostat and fractionated stereotactic
re-irradiation therapy for recurrent high grade gliomas.
J
Neurooncol. 2016 May;127(3):535-9. doi: 10.1007/s11060-016-2059-3.
Epub 2016 Jan 29.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
IMMUNOTHERAPY
|
|
.
|
Cloughesy TF, Landolfi J, Vogelbaum MA, Ostertag D, Elder JB,
Bloomfield S, Carter B, Chen CC, Kalkanis SN, Kesari S, Lai A, Lee
IY, Liau LM, Mikkelsen T, Nghiemphu P, Piccioni D, Accomando W,
Diago OR, Hogan DJ, Gammon D, Kasahara N, Kheoh T, Jolly DJ,
Gruber HE, Das A, Walbert T.
Durable Complete Responses
in Some Recurrent High Grade Glioma Patients Treated with Toca 511
& Toca FC.
Neuro Oncol. 2018 May 12. doi:
10.1093/neuonc/noy075. [Epub ahead of print]
Source
|
Abstract
| Full
text |
Similar
articles
|
|
|
|
Cloughesy
TF, Landolfi J, Hogan DJ, Bloomfield S, Carter B, Chen CC, Elder
JB, Kalkanis SN, Kesari S, Lai A, Lee IY, Liau LM, Mikkelsen T,
Nghiemphu PL, Piccioni D, Walbert T, Chu A, Das A, Diago OR,
Gammon D, Gruber HE, Hanna M, Jolly DJ, Kasahara N, McCarthy D,
Mitchell L, Ostertag D, Robbins JM, Rodriguez-Aguirre M, Vogelbaum
MA.
Phase
1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for
recurrent high-grade glioma.
Sci
Transl Med. 2016 Jun 1;8(341):341ra75. doi:
10.1126/scitranslmed.aad9784.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
|
Fenstermaker
RA, Ciesielski MJ, Qiu J, Yang N, Frank CL, Lee KP, Mechtler LR,
Belal A, Ahluwalia MS, Hutson AD.
Clinical
study of a survivin long peptide vaccine (SurVaxM) in patients
with recurrent malignant glioma.
Cancer
Immunol Immunother. 2016 Nov;65(11):1339-1352. Epub 2016 Aug 30.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
.
|
Kikuchi R, Ueda R, Saito K, Shibao S, Nagashima H, Tamura R,
Morimoto Y, Sasaki H, Noji S, Kawakami Y, Yoshida K, Toda M.
A
Pilot Study of Vaccine Therapy with Multiple Glioma
Oncoantigen/Glioma Angiogenesis-Associated Antigen Peptides for
Patients with Recurrent/Progressive High-Grade Glioma.
J
Clin Med. 2019 Feb 20;8(2). pii: E263. doi: 10.3390/jcm8020263.
Source
| Full
text | Similar
articles
|
|
|
|
Strebe
JK, Lubin JA, Kuo JS.
"Tag
Team" Glioblastoma Therapy: Results From a Phase 1 Trial of
Toca 511 and 5-Fluorocytosine for Recurrent High-Grade Glioma.
Neurosurgery.
2016 Dec;79(6):N18-N20.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
LASER
ABLATION
|
|
|
Rodriguez
A, Tatter SB.
Laser
Ablation of Recurrent Malignant Gliomas: Current Status and Future
Perspective.
Neurosurgery.
2016 Dec;79 Suppl 1:S35-S39.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
LASER
THERMAL THERAPY
|
|
|
Lee
I, Kalkanis S, Hadjipanayis CG.
Stereotactic
Laser Interstitial Thermal Therapy for Recurrent High-Grade
Gliomas.
Neurosurgery.
2016 Dec;79 Suppl 1:S24-S34.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
NOTCH
SIGNALING INHIBITORS
|
|
|
Pan
E, Supko JG, Kaley TJ, Butowski NA, Cloughesy T, Jung J, Desideri
S, Grossman S, Ye X, Park DM.
Phase
I study of RO4929097 with bevacizumab in patients with recurrent
malignant glioma.
J
Neurooncol. 2016 Dec;130(3):571-579. Epub 2016 Nov 8.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
PSEUDOPROGRESSION
|
|
|
Belliveau JG, Bauman GS, Macdonald D, Macdonald M, Klassen LM,
Menon RS.
Apparent transverse relaxation (R2∗) on
MRI as a method to differentiate treatment effect
(pseudoprogression) versus progressive disease in chemoradiation
for malignant glioma.
J Med Imaging Radiat Oncol. 2017
Nov 30. doi: 10.1111/1754-9485.12694. [Epub ahead of print]
Source
|
Abstract
| Full
text |
Similar
articles
|
|
|
RADIOTHERAPY
|
|
|
Arvold ND, Shi DD, Aizer AA, Norden AD, Reardon DA, Lee EQ, Nayak
L, Dunn IF, Golby AJ, Johnson MD, Claus EB, Chiocca EA, Ligon KL,
Wen PY, Alexander BM.
Salvage re-irradiation for
recurrent high-grade glioma and comparison to bevacizumab alone.
J Neurooncol. 2017 Oct 3. doi:
10.1007/s11060-017-2611-9. [Epub ahead of print]
Source
|
Abstract
| Full
text |
Similar
articles
|
|
|
|
Dong
Y, Fu C, Guan H, Zhang T, Zhang Z, Zhou T, Li B.
Re-irradiation
alternatives for recurrent high-grade glioma.
Oncol
Lett. 2016 Oct;12(4):2261-2270.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
|
Møller S, Munck Af Rosenschöld P, Costa J, Law I,
Poulsen HS, Engelholm SA, Engelholm S.
Toxicity and
efficacy of re-irradiation of high-grade glioma in a phase I dose-
and volume escalation trial.
Radiother Oncol. 2017 Oct
17. pii: S0167-8140(17)32625-7. doi: 10.1016/j.radonc.2017.09.039.
[Epub ahead of print]
Source
|
Abstract
| Full
text |
Similar
articles
|
|
|
.
|
Reynaud T, Bertaut A, Farah W, Thibouw D, Crehange G, Truc G,
Vulquin N.
Hypofractionated Stereotactic Radiotherapy as
a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center
Experience.
Technol Cancer Res Treat. 2018 Jan
1;17:1533033818806498. doi: 10.1177/1533033818806498.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Shen CJ, Kummerlowe MN, Redmond KJ, Martinez-Gutierrez JC, Usama
SM, Holdhoff M, Grossman SA, Laterra JJ, Strowd RE, Kleinberg LR.
Re-irradiation for malignant glioma: Toward patient
selection and defining treatment parameters for salvage.
Adv
Radiat Oncol. 2018 Jul 10;3(4):582-590. doi:
10.1016/j.adro.2018.06.005. eCollection 2018 Oct-Dec.
Source
| Full
text |
Similar
articles
|
|
|
RADIOSURGERY
|
|
.
|
Cheon YJ, Jung TY, Jung S, Kim IY, Moon KS, Lim SH.
Efficacy
of Gamma Knife Radiosurgery for Recurrent High-Grade Gliomas with
Limited Tumor Volume.
J Korean Neurosurg Soc. 2018
Jul;61(4):516-524. doi: 10.3340/jkns.2017.0259. Epub 2018 Jul 1.
Source
|
Abstract
| Full
text |
Similar
articles
|
|
|
.
|
Ene CI, Macomber MW, Barber JK, Ferreira MJ, Ellenbogen RG,
Holland EC, Rockhill JK, Silbergeld DL, Halasz LM.
Patterns
of Failure After Stereotactic Radiosurgery for Recurrent
High-Grade Glioma: A Single Institution Experience of 10 Years.
Neurosurgery. 2018 Dec 20. doi: 10.1093/neuros/nyy520.
[Epub ahead of print]
Source
| Full
text | Similar
articles
|
|
|
.
|
Wang C, Sun W, Kirkpatrick J, Chang Z, Yin FF.
Assessment
of concurrent stereotactic radiosurgery and bevacizumab treatment
of recurrent malignant gliomas using multi-modality MRI imaging
and radiomics analysis.
J Radiosurg SBRT.
2018;5(3):171-181.
Source
|
Abstract
| Full
text |
Similar
articles
|
|
|
SURGERY
|
|
|
|
AFTER
TREATMENT WITH BEVACIZUMAB
|
|
|
Blumenthal DT, Kanner AA, Aizenstein O, Cagnano E, Greenberg A,
Hershkovitz D, Ram Z, Bokstein F.
Surgery for recurrent
high grade glioma after treatment with bevacizumab.
World
Neurosurg. 2017 Nov 25. pii: S1878-8750(17)32028-4. doi:
10.1016/j.wneu.2017.11.105. [Epub ahead of print]
Source
|
Abstract
| Full
text |
Similar
articles
|
ANAPLASTIC
GLIOMAS
|
|
|
Im JH, Hong JB, Kim SH, Choi J, Chang JH, Cho J, Suh CO.
Recurrence patterns after maximal surgical resection and
postoperative radiotherapy in anaplastic gliomas according to the
new 2016 WHO classification.
Sci Rep. 2018 Jan
15;8(1):777. doi: 10.1038/s41598-017-19014-1.
Source
|
Abstract
| Full
text |
Similar
articles
|
|
|
REPEAT
SURGERY
|
|
.
|
Salvati M, Pesce A, Palmieri M, Floriana Brunetto GM, Santoro A,
Frati A.
The Role and Real Effect of an Iterative
Surgical Approach for the Management of Recurrent High-Grade
Glioma: An Observational Analytic Cohort Study.
World
Neurosurg. 2019 Jan 3. pii: S1878-8750(18)32941-3. doi:
10.1016/j.wneu.2018.12.118. [Epub ahead of print]
Source
| Full
text | Similar
articles
|
|
|
VEGFR
INHIBITORS
|
|
|
Zhang
H, Chen F, Wang Z, Wu S.
Successful
treatment with apatinib for refractory recurrent malignant
gliomas: a case series.
Onco
Targets Ther. 2017 Feb 14;10:837-845. doi: 10.2147/OTT.S119129.
eCollection
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
|
|
|
▲
|
